6505--Montelukast 10mg Tablet (VA-25-00102867)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79725R0061
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is soliciting proposals for Montelukast 10mg Tablets through a firm fixed price, indefinite-delivery requirements contract. This pharmaceutical procurement seeks to establish a single supply source for Montelukast 10mg Tablets to be distributed through VA and Department of Defense Pharmaceutical Prime Vendor Programs, serving multiple federal agencies including the Indian Health Service and Bureau of Prisons. Offerors must provide a unique 11-digit NDC number, demonstrate FDA approval, and comply with current Good Manufacturing Practice (cGMP) standards. Awards will be made to the lowest-price technically acceptable offer that meets all solicitation requirements, with pricing evaluated to include a mandatory 0.5% Cost Recovery Fee. The proposal submission deadline has been extended to November 4, 2025, at 2:30 PM Central Standard Time, providing offerors additional time to prepare and submit their offers electronically.
This solicitation does not include a small business set-aside designation. The contract structure includes a base year plus four one-year option periods, covering a total of five years of supply requirements. The solicitation encompasses three primary line items for different bottle sizes: 30-tablet, 90-tablet, and 500/1000-tablet bottles, with specific packaging requirements including safety-cap capabilities and barcode labeling. No incumbent contractor information or specific award value is disclosed in the available solicitation documents. Performance of the contract will involve pharmaceutical manufacturing and supply chain management in compliance with FDA requirements and packaging specifications, with products ultimately distributed to multiple federal agencies through established Pharmaceutical Prime Vendor distribution channels.
Notice text
3 versions
Update #3 · Latest ·
Page 1 of
Page 1 of
Page 1 of
Page 1 of
Amendment to extend the due date of offers November 4, 2025, 2:30PM CT
Update #2 ·
Amendment to include a corrected version of the solicitation.
Update #1 ·
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0061 0002.docx | DOCX document | |
| 36E79725R0061 0001.docx | DOCX document | |
| 36E79725R0061.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Montelukast 10mg Tablet | Award Notice | |
| This notice | Solicitation | |
| 6505--Montelukast 10mg Tablet (VA-25-00102867) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Ramipril Capsules RFP | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity